FR2915381B1 - Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c - Google Patents

Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c

Info

Publication number
FR2915381B1
FR2915381B1 FR0703055A FR0703055A FR2915381B1 FR 2915381 B1 FR2915381 B1 FR 2915381B1 FR 0703055 A FR0703055 A FR 0703055A FR 0703055 A FR0703055 A FR 0703055A FR 2915381 B1 FR2915381 B1 FR 2915381B1
Authority
FR
France
Prior art keywords
soybeans
prepare
composition
active ingredient
glycine max
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0703055A
Other languages
English (en)
Other versions
FR2915381A1 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Jean Marie Botto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vincience SA
Original Assignee
Vincience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vincience SA filed Critical Vincience SA
Priority to FR0703055A priority Critical patent/FR2915381B1/fr
Publication of FR2915381A1 publication Critical patent/FR2915381A1/fr
Application granted granted Critical
Publication of FR2915381B1 publication Critical patent/FR2915381B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
FR0703055A 2007-04-27 2007-04-27 Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c Active FR2915381B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0703055A FR2915381B1 (fr) 2007-04-27 2007-04-27 Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0703055A FR2915381B1 (fr) 2007-04-27 2007-04-27 Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c

Publications (2)

Publication Number Publication Date
FR2915381A1 FR2915381A1 (fr) 2008-10-31
FR2915381B1 true FR2915381B1 (fr) 2012-06-08

Family

ID=38738950

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0703055A Active FR2915381B1 (fr) 2007-04-27 2007-04-27 Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c

Country Status (1)

Country Link
FR (1) FR2915381B1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2938769B1 (fr) * 2008-11-26 2010-12-31 Isp Investments Inc Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis viniferal.)en tant que principe actif activateur du cytochrome c
FR2944017B1 (fr) 2009-04-02 2012-03-09 Isp Investments Inc Nouveaux peptides eclaircissants activateurs du proteasome et compositions les contenant
FR2944018B1 (fr) 2009-04-02 2012-03-09 Isp Investments Inc Nouveaux peptides anti-age activateurs du proteasome et compositions les contenant
FR2944798B1 (fr) * 2009-04-23 2013-05-10 Isp Investments Inc Hydrolysats peptidiques eclaircissants activateurs du proteasome et compositions les contenant
FR2944796B1 (fr) * 2009-04-23 2013-08-02 Isp Investments Inc Hydrolysats peptidiques eclaircissants activateurs du proteasome et compositions les contenant
FR2944797B1 (fr) 2009-04-23 2013-05-10 Isp Investments Inc Hydrolysats peptidiques activateurs du proteasome et compositions les contenant
FR2944795B1 (fr) * 2009-04-23 2013-08-02 Isp Investments Inc Hydrolysats peptidiques activateurs du proteasome et compositions les contenant
FR2948876B1 (fr) 2009-08-07 2011-11-04 Oreal Association d'un rayonnement lumineux et d'un agent de nature peptidique augmentant l'expression d'un substrat de la cytochrome c oxydase pour ameliorer notamment l'apparence de la peau et/ou du cheveu
FR2951947B1 (fr) * 2009-11-03 2022-01-07 Isp Investments Inc Utilisation d'une composition comprenant un extrait peptidique de riz non fermente pour stimuler la pousse des cheveux
FR2987998B1 (fr) 2012-03-19 2014-04-25 Isp Investments Inc Composition cosmetique comprenant un systeme activateur de la proteine trf2 a action synergique constitue d'une association d'un extrait peptidique de soja et de levure et ses utilisations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824702A (en) * 1996-06-07 1998-10-20 Mount Sinai School Of Medicine Of The City University Of New York Genistein as a preventive against ultraviolet induced skin photodamage and cancer
US8431550B2 (en) * 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
CZ20023935A3 (cs) * 2001-02-14 2003-05-14 Matthias Rath Preparáty biochemických sloučenin majících roli v bioenergetickém metabolismu buněk a způsob jejich použití
FR2854069B1 (fr) * 2003-04-23 2006-03-10 Silab Sa Procede d'obtention d'un principe actif a partir du soja, ayant des proprietes anti-vieillissement, compositions et utilisations de ces compositions a visee cosmetique

Also Published As

Publication number Publication date
FR2915381A1 (fr) 2008-10-31

Similar Documents

Publication Publication Date Title
FR2915381B1 (fr) Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c
FR2915378B1 (fr) Utilisation d'un principe actif issu du soja (glycine max l.) pour preparer une composition destinee a proteger les mitochondries
FR2918893B1 (fr) Utilisation d'un principe actif issu du lin pour preparer une composition destinee a activer le cytochrome c
FR2915380B1 (fr) Utilisateur d'un principe actif issu du riz (oryza sativa l) pour preparer une composition destinee a activer le cytochrome c
FR2915384B1 (fr) Utilisation d'un principe actif issu du soja (glycine maxl.) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.
FR2915382B1 (fr) Utilisation d'un principe actif issu du mais (zea mays l) pour preparer une composition destinee a activer le cytochrome c
NO20092004L (no) 2-[L-fenyl-5-hydroksy-4-alfa-metyl-heksahydrosyklopenta[f]indazol-5-yl]etylfenylderivater som glukokortikoidreseptorligandere
NI200800290A (es) Moduladores bencimidazólicos de vr1
UA116809C2 (uk) Застосування агрохімічних сумішей для збільшення життєздатності рослини
FR2915379B1 (fr) Utilisation d'un principe actif issu du riz (oryza sativa l) pour preparer une composition destinee a proteger les mitochondries
EP3586631A3 (fr) Composition pour la santé des plantes
AU2007208169A8 (en) Use of gallium to treat biofilm-associated infectons
EA201290183A1 (ru) Бензодиазепиновый ингибитор бромодомена
EA201070549A1 (ru) Жидкие композиции lh
SV2009003376A (es) Derivados de aril isoxazolinas insecticidas
BR112012009214A2 (pt) compostos
BR112013016595A2 (pt) inibidores de neprilisina
EA200970486A1 (ru) Соединения для ингибирования митоза
DK1978981T3 (da) Præparater til vaginal anvendelse
EA201170703A1 (ru) Производные адамантилбензамида
UY30610A1 (es) Moduladores de mglur5
EA200802054A1 (ru) Ингибиторы фермента
MY151295A (en) Pyrimidyl indoline compound
WO2011150190A3 (fr) Composés inhibiteurs du virus de l'hépatite c (hcv) et leurs procédés d'utilisation
MA32150B1 (fr) Inhibiteurs heterocycliques de la stearoyl-coa desaturase

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18